Veterinary Blog for Education, Careers, and Real Vet Life

Welcome to the Vet Candy Blog—your go-to destination for veterinary education, career growth, and real-life insights from the world of animal health.

From free RACE-approved CE courses and clinical updates to NAVLE prep and career advice, our content is designed for veterinarians, vet techs, and students who want to stay informed, inspired, and ahead in their careers.

A young woman with curly hair smiling while looking at her phone in a bright indoor setting.

Latest Veterinary News & Clinical Insights

My Vet Candy 1/21/26 My Vet Candy 1/21/26

FDA Grants Full Approval to KBro Vet CA-1 Chewable for Dogs with Idiopathic Epilepsy

Big news in veterinary neurology: the U.S. Food and Drug Administration (FDA) has granted full approval to KBroVet® (potassium bromide chewable tablets) for the control of seizures in dogs diagnosed with idiopathic epilepsy. This makes it the first FDA approved medication for idiopathic epilepsy in dogs.

My Vet Candy 1/21/26 My Vet Candy 1/21/26

FDA Grants Full Approval of a Drug to Control Seizures in Dogs with Idiopathic Epilepsy

The U.S. Food and Drug Administration has granted full approval to KBroVet (potassium bromide chewable tablets) for the control of seizures in dogs with idiopathic epilepsy, a type of seizure disorder without a known cause.

Vet Candy 6/17/25 Vet Candy 6/17/25

KBroVet-CA1: The Convenient, Conditionally FDA-Approved Solution for Canine Seizure Control

KBroVet-CA1 has redefined the veterinary approach to canine idiopathic epilepsy by combining scientific validation with practical administration. Its conditional FDA approval bridges a critical gap between unregulated supplements and human-adapted medications, offering a purpose-built solution for canine patients.

Jill Lopez 5/15/25 Jill Lopez 5/15/25

What You Should Know About KBroVet®-CA1: The Once-Daily Option for Canine Epilepsy

Now, with the introduction of KBroVet®-CA1 by PRN Pharmacal, veterinarians have a new, promising solution. This is the first FDA-conditionally approved potassium bromide medication designed specifically for dogs with idiopathic epilepsy—and it brings with it a host of advantages for both clinicians and clients.

Jill Lopez 3/21/25 Jill Lopez 3/21/25

Exploring the Link Between Epilepsy and Sleep Disturbances in Dogs: What Every Veterinarian Should Know

The relationship between epilepsy and sleep has been widely studied in humans, but what about our canine companions? A groundbreaking study by Alejandra Mondino, Julie Nettifee, and Karen R. Muñana delves into the sleep patterns of dogs with idiopathic epilepsy (IE) and compares them to healthy, non-epileptic dogs. Their findings highlight significant sleep disturbances in dogs with epilepsy, underscoring the importance of managing both seizure activity and sleep quality in veterinary care.

My Vet Candy 2/20/25 My Vet Candy 2/20/25

Unlocking the Canine Brain: New Imaging Technology Offers Hope for Dogs with Epilepsy

Idiopathic epilepsy (IE) is the most common neurological disorder in dogs, affecting countless pets and their owners worldwide. While anti-seizure medications (ASMs) are often prescribed to manage the condition, nearly one-third of dogs with IE remain resistant to treatment, leaving veterinarians and pet parents searching for better diagnostic and therapeutic solutions. Now, cutting-edge research is exploring a revolutionary imaging technique that could transform how veterinary medicine approaches this complex disease.

Vet Candy welcomes relevant industry news, press releases, and high-quality content that provides value to veterinary professionals. Submissions should focus on clinical insights, innovation in animal health, or meaningful industry developments.
All submissions are reviewed by our editorial team to ensure they align with our content standards and audience interests. To inquire about opportunities, please contact our team through the website.
Vet Candy focuses on content that is educational, engaging, and relevant to veterinarians, vet techs, and veterinary students. This includes clinical updates, industry news, career insights, and expert perspectives that help professionals stay informed and grow in their careers.
Yes, Vet Candy offers opportunities for companies and organizations to share important updates, product news, and industry announcements through sponsored content, press features, and integrated campaigns—helping you reach a highly engaged veterinary audience.
You can reach us anytime via our contact page or email. We aim to respond quickly—usually within one business day.
Vet Candy is committed to providing content that is accurate, balanced, and relevant to veterinary professionals. Our editorial team works to maintain high journalistic standards by reviewing content for clarity, credibility, and educational value. We aim to present information in a way that reflects a range of perspectives within the veterinary industry.
We strive for accuracy in everything we publish, but if you notice an error or outdated information, we encourage you to reach out to our team. Vet Candy is committed to transparency and will review and update content as needed to ensure it remains accurate and reliable.
Yes, Vet Candy regularly reviews and updates content to maintain accuracy and relevance. When necessary, corrections or edits are made to ensure our content reflects the most current and reliable information available.